Cambridge, MA-based Helicos BioSciences (NASDAQ:[[ticker:HLCS]]), a developer of genetic analysis technology for molecular diagnostics, said today it has named Ivan Trifunovich as the company’s president and CEO. Trifunovich, who was named the firm’s executive chairman on September 15 and has previously served as its consultant, is a former senior vice president of Third Wave Technologies, a molecular diagnostics company that is now part of Bedford, MA-based Hologic (NASDAQ:[[ticker:HOLX]]). Helicos’s board of directors asked its former CEO, Ron Lowy, to step down from that post. Lowy has returned to his seat on the firm’s board of directors.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
